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As mortality rates decline, the global burden 
of neurological disease is on the rise. Stroke 
affects 15 million people worldwide each 
year, contributing to 5 million deaths and an-
other 5 million left with permanent disability 
(Vos et al., 2017).  By 2050, the rate of de-
mentia is expected to triple to 115 million 
worldwide (Prince et al ., 2013). Over the last 
twenty years, we have seen dramatic ad-
vances in the treatment of neurological dis-
ease.  The National Institute of Neurological 
Disease (NINDs) trial that tested t-PA 
opened the door for successful treatment of 
acute stroke reducing death and disability 
(Koroshtez, 1996). In 2015, the results of five 
trials that evaluated endovascular treatments 
showed the profound benefit of early removal 
of thrombus in anterior circulation strokes 
(Goyal et al., 2016). Lessons from Finland 
taught us to reorganize our care, bypassing 
the red tape of  “checking in patients” to 
adopt a “door to CT” approach that substan-
tially reduced “door to needle” times and im-
proved outcome (Lindsberg et al., 2006). In 
developed countries, medical progress has 
promoted the growth of specialized care units 
and tailored treatment for stroke, traumatic 
brain injury, dementia and Parkinson’s dis-
ease.  These advances have opened the 
door for dedicated nursing training with certi-
fication programs like the Neuro Criticalcare 
Society’s Emergency Neuro Life Support 
(ENLS) aimed at improving care in the first 
critical hour after any neurological emergen-
cy. However, all of these advances come at a 
cost. 
 
As the care of neurological disease becomes 
more sophisticated, the countries that are 
least able to afford the equipment or mobilize 
highly subspecialized teams will experience a 
widening gap (Carroll, 2017). Treatment that 
relies on extensive resources may be imprac-
tical when it is accomplished at the expense 
of other critical services. It’s impossible to 
consider an endovascular approach to stroke 
care when two patients are sharing a bed 
and generator power is at best, intermittent. 
The challenge is to surround these countries 
with range of solutions to provide best care 
within their existing resources.  
 
A thoughtful evaluation that assumes nothing 
is essential. In some countries, nurses still do 
not perform a neurological exam. This level 
of evaluation still resides at the physician 
level. Changing patterns of care is highly po-
litical and requires an advanced working 
knowledge of education standards, workforce 
utilization and the available support for 
change. The acceptance and willingness to 
change from the inside and to see things in a 
different way is required. “Outsiders” cannot 
push something that is not supported from 
within. For example, if a nurse is responsible 
for the care of 45 patients, the overwhelming 
burden of basic care tasks may exclude more 
advanced neurological evaluation. The physi-
cal challenges of available supplies may also 
be a barrier.  They may lack the funds to pur-
chase or maintain neuromonitoring equip-
ment or have access to the qualified staff 
needed to insert such devices. Local roles 
and responsibilities may differ substantially 
and education programs must be carefully 
crafted with the patient as the central focus.  
 
The World Federation of Neuroscience Nurs-
es (WFNN) represents more than 8,800 
members world-wide with representation 
from 13 countries. Initiatives over the last 
decade have been aimed at connecting nurs-
es globally to promote the professional prac-
tice of neuroscience nursing, foster an open 
dialogue about the care of neurological dis-
ease that crosses cultures and national 
boundaries and support the development of 
professional neuroscience nursing societies. 
WFNN education projects have been con-
centrated on basic skills like the neurological 
examination that is the cornerstones of pa-
tient management. In partnership with the 
member nations, it is the Quadrennial Con-
gress that connects nurses from across the 
world to share nursing research, expand the 
fund of knowledge and forge international 
friendships that raise the standard of care 
worldwide.  
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As the global burden of neurological disease 
rises, we must leverage professional partner-
ships to improve regional education. The 
Australasian Neuroscience Nurses Associa-
tion and other WFNN members must work 
together to meet the growing challenge by 
improving access to basic neuroscience 
nursing training. Public education focused on 
prevention, is equally important. Key partners 
working in tandem with this effort include the 
European Association of Neuroscience Nurs-
es (EANN), Neurocritical Care Society, 
(NCS), World Federation of Neurological So-
cieties (WFNS), The World Stroke Organiza-
tion (WSO), the Movement Disorders Society 
(MDS), the World Parkinson’s Association 
(WPA), The International League Against 
Epilepsy, (ILAE), The Multiple Sclerosis Inter-
national Federation (MSIF) the World Feder-
ation of Neurorehabilitation (WFNR) and nu-
merous others.  
 
In 2021, the WFNN will welcome nurses from 
across the world to join us in Darwin, Austral-
ia for the 13th Quadrennial Congress. The 
Congress represents a unique opportunity to 
learn from one another and advance global 
bank of knowledge. Share your nursing 
knowledge with the world! More information 
is available on the website at www.wfnn.org  
As a benefit of membership in ANNA, your 
membership with the WFNN is already paid. 
If you have developed leadership skills and 
you are looking for a global challenge, WFNN 
is accepting applications for leadership posi-
tions. Information can be found at https://
wfnn.org/about.  
 
We look forward to meeting you in  
Darwin! 
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